Form 8-K · Current report
News Corp 8-K, filed Oct 19, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000231
Summary
News Corp filed a Form 8-K covering its daily buy-back disclosures to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to US$1 billion of Class A and Class B common stock repurchases. As of the 16 October 2026 trading day, the company had bought back 58,482 Class A shares for US$1,763,776.18, bringing cumulative purchases under the program to roughly US$537,954,520.
Key points
- News Corp repurchased 58,482 Class A common shares on 16 October 2026 at prices between US$29.84 and US$30.66.
- Cumulative buy-backs under the 2025 Repurchase Program total about US$537,954,520 of the US$1 billion authorized.
- The program, authorized 15 July 2025, covers Nasdaq-listed Class A and Class B common stock and excludes ASX-listed CDIs.
- The buy-back was reported as an "Other buy-back" made to enhance shareholder value, with no shareholder approval required.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.